Revenio Group Corporation: Revenio divests its last

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Revenio Group Corporation: Revenio divests its last software business by selling its last non-core company

Revenio Group Corporation, Stock Exchange Release, 7 May 2015 at 12:10

REVENIO DIVESTS ITS SOFTWARE BUSINESS BY SELLING ITS LAST NON-CORE COMPANY

Revenio Group Corporation has sold the entire share capital of Done Software Solutions Oy (DSS) to Roima Intelligence Oy. DSS, which had been transferred to discontinued operations, formed part of the Revenio Technology and Services segment's Software business. In accordance with its strategy, Revenio is focusing on health technology and has now finalized the related measures by selling DSS, its last non-core company.

The parties have agreed not to disclose the sale price. The sale of Done Software Solutions Oy, which was transferred to discontinued operations at the end of 2014, will not affect Revenio Group Corporation's financial performance for 2015 or its previously announced profit guidance. It is estimated that the sale will boost the Group's cash flow by approximately EUR 1.6 million.

"Done Software Solutions was the last non-strategic company within our Group and we are happy that we found for DSS and its personnel the right kind of buyer that will continue to develop its business as part of a larger whole. Now that we have finalized the divestment of these non-core operations, we can focus all of our resources on developing our health technology businesses. We aim to develop even more efficient and easily adopted methods for the early-stage detection of diseases that are important to public health. The focus of our screening technology lies in the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process," says Olli-Pekka Salovaara, President and CEO of Revenio Group.

For further information, please contact: President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi www.revenio.fi

DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is in tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy, which specializes in osteoporosis screening and monitoring. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings in health care via preventive measures. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. Revenio aims at developing even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology lies on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating profit (EBIT) from continuing operations standing at 27.5%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki.

HUG#1919314

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 188

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 296

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 81

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 139

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Historic China-Russia-US Summit Aims for Global Stability

Updated Category News Views 85

The Weight of History in Shenzhen When the big players decide to talk face-to-face, it's more than just a photo op. This week in Shenzhen, the leaders of China, Russia, and the United States are doing just that. And let me tell you, it's the kind of gathering that can either stabilize the gears of global politics or grease the wheels of tension. This chinwag isn't just...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 264

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 65

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
Clarivate's 2026 Research List Carries a Trust Test

Updated Category News Views 192

Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...

Continue Reading
Texas Restaurants Get a New Read on Customer Demand

Updated Category News Views 34

Texas restaurant owners are being handed a sharper flashlight, and frankly it is overdue. HundredX and the Texas Restaurant Association have launched a pilot that gives TRA members access to the HundredX Restaurant Insights Platform, aiming to bring customer and market intelligence to the independent operators and regional chains that usually cannot pay big-company prices...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 173

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading

Top 5 Most Recently Viewed Articles

BrainsWay Achieves Record Revenue and Strategic Growth in 2025

Updated Category News Views 256

Exploring BrainsWay's Remarkable Q2 Results BrainsWay Ltd. (NASDAQ: BWAY), a prominent player in neurostimulation treatments for mental health disorders, recently announced its extraordinary financial performance for the second quarter of 2025. The company achieved a record quarterly revenue of $12.6 million, marking a notable 26% increase compared to the same quarter in...

Continue Reading
CDC Foundation Pushes for Urgent Ebola Response

Updated Category News Views 33

Sounding the Alarm on Ebola In a world where crises come and go like the seasons, the latest Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda ought to command our undivided attention. We've seen this movie before, yet here we are with an Ebola variant—Bundibugyo this time—that threatens to spiral out of control. The CDC Foundation has sounded...

Continue Reading
Apple Faces Class Action Over Alleged AI Misrepresentation

Updated Category News Views 279

Apple's Legal Challenges: Class Action Lawsuit Over AI Features Pomerantz LLP has announced the initiation of a class action lawsuit against Apple Inc. (NASDAQ: AAPL) and select executives, focusing on claims surrounding the company’s advertised artificial intelligence capabilities. This legal action stems from allegations of misleading information disseminated to...

Continue Reading
Celebrate Togetherness with Aperol's Inaugural Aperolidays

Updated Category News Views 240

Introducing Aperolidays: A Celebration of Togetherness Aperol, the beloved Italian aperitivo, is stepping into the holiday spirit by announcing the inaugural Aperolidays. This unique celebration aims to infuse joy and connection into the winter season, inviting everyone to gather and enjoy the quintessential Italian way of life. New Festive Merchandise and Experiences...

Continue Reading
Acorai Unveils Breakthroughs in Heart Failure Monitoring Solutions

Updated Category News Views 233

Acorai's Impactful Results in Heart Failure Management Acorai, a clinical-stage company focused on innovative ways to manage heart failure, recently shared impressive findings from the extensive 1,600-patient CAPTURE-HF study. The study focused on a novel, non-invasive multi-sensor device aimed at improving the way healthcare professionals monitor heart failure patients....

Continue Reading